Janus Henderson Group
AMRX icon

Janus Henderson Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Janus Henderson Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$947K Hold
76,216
– – ﹤0.01% 1719
2025
Q4 		$960K Buy
76,216
+17,416
+30% +$199K ﹤0.01% 1695
2025
Q3 		$589K Hold
58,800
– – ﹤0.01% 1928
2025
Q2 		$476K Hold
58,800
– – ﹤0.01% 1981
2025
Q1 		$486K Hold
58,800
– – ﹤0.01% 1974
2024
Q4 		$466K Hold
58,800
– – ﹤0.01% 2067
2024
Q3 		$489K Hold
58,800
– – ﹤0.01% 2045
2024
Q2 		$374K Sell
58,800
-570
-1% -$3.62K ﹤0.01% 2108
2024
Q1 		$359K Buy
59,370
+41
+0.1% +$231 ﹤0.01% 2159
2023
Q4 		$360K Buy
+59,329
New +$264K ﹤0.01% 2143
2023
Q2 		– Sell
-44,720
Closed -$62.6K – 2596
2023
Q1 		$62.6K Buy
44,720
+24,979
+127% +$49.7K ﹤0.01% 2647
2022
Q4 		$39.2K Buy
19,741
+1
+0% +$2 ﹤0.01% 2434
2022
Q3 		$40K Sell
19,740
-35
-0.2% -$98 ﹤0.01% 2138
2022
Q2 		$63K Buy
19,775
+49
+0.2% +$178 ﹤0.01% 2531
2022
Q1 		$83K Buy
19,726
+105
+0.5% +$465 ﹤0.01% 2586
2021
Q4 		$94K Buy
+19,621
New +$97.8K ﹤0.01% 2508
2019
Q2 		– Sell
-2,382,283
Closed -$33.8M – 1371
2019
Q1 		$33.8M Sell
2,382,283
-49,366
-2% -$652K 0.02% 666
2018
Q4 		$32.9M Sell
2,431,649
-291,529
-11% -$5.25M 0.02% 634
2018
Q3 		$60.4M Buy
2,723,178
+2,004,464
+279% +$42.2M 0.03% 538
2018
Q2 		$11.8M Buy
+718,714
New +$12.6M 0.01% 895

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Janus Henderson Group's AMRX Position: Q1 2026 in Review

Janus Henderson Group held its Amneal Pharmaceuticals (AMRX) position steady in Q1 2026 at 76,216 shares worth $947K. The position accounts for ﹤0.01% of the portfolio, ranked #1719.

Janus Henderson Group first reported a position in AMRX in Q2 2018 and has held it in 20 quarters since. The position peaked at $60.4M in Q3 2018. 317 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Janus Henderson Group held 76,216 shares of Amneal Pharmaceuticals worth $947K as of Q1 2026.
  • Janus Henderson Group left its Amneal Pharmaceuticals share count unchanged in Q1 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1719 holding.
  • Janus Henderson Group first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 20 quarters since.
  • Janus Henderson Group's Amneal Pharmaceuticals position peaked at $60.4M in Q3 2018.
  • 317 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.